Abstract
A review of the literature shows that cholecalciferol, ergocalciferol and calcifediol are currently used in foreign and domestic practice to increase vitamin D levels, while there is no consensus on the effectiveness, necessity and possibility of using one or another type of vitamin D supplements. In this regard, we conducted statistical studies of the effectiveness of increasing the level of vitamin D in the patient's blood serum, and also made an analysis of literary sources on the biological activity and safety of the use of cholecalciferol, ergocalciferol and calcifediol. Research has shown that cholecalciferol is currently the most commonly used vitamin D supplement, with calcifediol gaining popularity, which is an order of magnitude superior to cholecalciferol in terms of dose-time-effectiveness. Clinical studies by foreign authors have shown that the use of calcifediol in some cases is accompanied by an improvement in muscle function, a decrease in systolic blood pressure, restoration of acceptable levels of parathyroid hormone and other positive biological effects. Also, there is no doubt about the safety and absence of toxic effects of calcifediol as a therapeutic agent. Most foreign experts studying the applicability of calcifediol for the treatment of patients indicate its increased hydrophilicity, which provides it with the greatest advantages in the treatment of diseases associated with a decrease in absorption in the intestine. It is clear that large-scale laboratory and clinical studies are needed to obtain final conclusions about the therapeutic usefulness, scope, dosage and duration of use of calcifediol, however, the prospect of widespread use of this drug as a therapeutic agent is also beyond doubt.
Publisher
PANORAMA Publishing House
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference37 articles.
1. 1. Суплотова Л.А., Авдеева В.А., Пигарова Е.А., Рожинская Л.Я., Трошина Е.А. Дефицит витамина D в России: первые результаты регистрового неинтервенционного исследования частоты дефицита и недостаточности витамина D в различных географических регионах страны. Проблемы эндокринологии. 2021; 67 (2): 84-92. doi: https://doi.org / 10.14341 / probl12736 / Suplotova L.A., Avdeeva V.A., Pigarova E.A., Rozhinskaya L.Ya., Troshina E.A. Vitamin D deficiency in Russia: the first results of a register-based non-interventional study of the frequency of vitamin D deficiency and insufficiency in various geographical regions of the country. Problemy jendokrinologii (Problems of endocrinology). 2021; 67 (2): 84-92. (in Russian) doi: https://doi.org / 10.14341 / probl12736
2. 2. Кривошеев В.В., Козловский И.В., Никитина Л.Ю. Влияние дефицита витамина D на заболеваемость и смертность населения северных территорий России. Санитарный врач. 2023; 4: 242-256. doi: 10.33920 / med-08-2304-05 / Krivosheev V.V., Kozlovsky I.V., Nikitina L.Yu. The effect of vitamin D deficiency on morbidity and mortality of the population of the northern territories of Russia. Sanitarnyj vrach (Sanitary doctor). 2023; 4: 242-256. (in Russian) doi: 10.33920 / med-08-2304-05
3. 3. Gonnelli S., Tomai Pitinca M.D., Camarri S., et al. Pharmacokinetic profile and effect on bone markers and muscle strength of two daily dosage regimens of calcifediol in osteopenic / osteoporotic postmenopausal women. Aging clinical and experimental research. 2021 Sep; 33 (9): 2539-2547 doi: 10.1007 / s40520-020-01779-7
4. 4. Cesareo R., Falchetti A., Attanasio R., et al. Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol? Nutrients. 2019; 11 (5): 1016. doi: https://doi.org / 10.3390 / nu11051016
5. 5. Alshahrani F., Aljohani N. Vitamin D: Deficiency, Sufficiency and Toxicity. Nutrients. 2013; 5 (9): 3605-3616. doi: https://doi.org / 10.3390 / nu5093605
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献